Product Information
RASUVO 25 MG/0.5 ML AUTOINJ is a brand product labeled by Medexus Pharma Inc., priced at $289.3650 per ML under NDC 59137054004. Its NADAC has been published 411 times since Jul 19, 2017.
FDA first approved this application on Jul 10, 2014.
The High Outlier badge above means this manufacturer's average price in the methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/.5mL
Manufacturer
Medexus Pharma Inc.NDC
59137054004
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA205776FDA Approved
7/10/2014
On Market Since
7/10/2014
Pharmacological Classes
Price Statistics
The NADAC for RASUVO 25 MG/0.5 ML AUTOINJ has been published 411 times since Jul 19, 2017, and over the history we have for it it has risen 28.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $289.3650 per ML |
|---|---|
| All-time high | $289.3650 (Sep 30, 2026) |
| All-time low | $225.7225 (Jul 19, 2017) |
| 52-week high | $289.3650 |
| 52-week low | $280.7228 |
| Median price | $253.2381 |
| Average price | $255.3520 |
| Largest weekly change | +6.4% (Nov 20, 2019) |
| Weeks tracked | 411 |
| Tracking since | Jul 19, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Medexus Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methotrexate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Folate Analog Metabolic Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RASUVO 25 MG/0.5 ML AUTOINJ?
The current National Average Drug Acquisition Cost (NADAC) for RASUVO 25 MG/0.5 ML AUTOINJ, manufactured by Medexus Pharma Inc., is $289.3650 per ML (NDC 59137054004), effective Sep 30, 2026.
How has the price of RASUVO 25 MG/0.5 ML AUTOINJ changed over time?
Over the history we have for it, the NADAC for RASUVO 25 MG/0.5 ML AUTOINJ has risen 28.2%. It has been tracked across 411 weekly CMS publications since Jul 19, 2017.
What are the highest and lowest recorded NADAC prices for RASUVO 25 MG/0.5 ML AUTOINJ?
Since Jul 19, 2017, the NADAC for RASUVO 25 MG/0.5 ML AUTOINJ has ranged from a low of $225.7225 (Jul 19, 2017) to a high of $289.3650 (Sep 30, 2026), with a median of $253.2381 per ML.
Are there cheaper alternatives to RASUVO 25 MG/0.5 ML AUTOINJ?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RASUVO 25 MG/0.5 ML AUTOINJ in a comparable dosage form, but none are currently priced below it.
Who manufactures RASUVO 25 MG/0.5 ML AUTOINJ?
RASUVO 25 MG/0.5 ML AUTOINJ (NDC 59137054004) is labeled by Medexus Pharma Inc., and CMS classifies it as a brand product.